Special Issue "Antimicrobial Properties of Phytocomplexes and Isolated Compounds"
Deadline for manuscript submissions: 31 October 2021.
Infectious diseases are a global burden that has been worsening in recent years due to the development of species resistant to multiple antibiotics. Therefore, the identification of antimicrobial agents of high potency which are active against MDR microorganisms is fundamental to overcome this issue.
Several plants and plant extracts have a long history of human usage in many countries for the treatment of pathologies due to infections, and they may represent important sources of active molecules with a great therapeutic potential and lesser side effects than conventional antibiotics.
Phytocomplexes’ antimicrobial activity often result from several molecules acting in synergy, and the clinical effects may be due to direct effects against microorganisms and indirect effects on the host immune system. When the phytocomplex has a direct strong antimicrobial activity that is not maintained with any of the isolated compounds, it should be considered for nutraceutical purposes. In the other cases, the medicinal plant may provide novel drug leads with antimicrobial activity.
Accordingly, it is desirable to promote scientific research where modern methods are applied to herbal medicines to identify phytocomplexes and isolated compounds which are active against MDR microorganisms, and molecular mechanisms should be defined.
This Special Issue is gathering manuscript submissions to increase the knowledge about the effects of phytocomplexes against microorganisms and to augment the number of leads that may be further studied in order to obtain new antibiotics which are also active against MDR microorganisms.
Submissions of studies about the antimicrobial effects of phytocomplexes and isolated compounds, where the possible synergistic effects of natural compounds with conventional antibiotics are also investigated, are most welcome.
Dr. Matteo Micucci
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- isolated compounds